EyePod Bayer

Välkomna till EyePod Bayer!I det här avsnittet möter vi Dr. Emad som delar sina erfarenheter och berättar bland annat om vad som inspirerade honom till att välja medicinsk retina som sitt specialistområde.Host: Shahin AeinehbandMedverkande: Imadeddin Abu Ishkheidem/Eyepod@bayer.com Hosted on Acast. See acast.com/privacy for more information.

I detta avsnitt samtalar vi med Sten Kjellström, disputerad överläkare inom ögonsjukdomar och idag VD för S:t Eriks ögonsjukhus i Stockholm. Det är nu i september 2022 cirka 2 år sedan det nya ögonsjukhuset öppnade. Sten tillträdde tjänsten som verkställande direktör för sjukhuset i april 2022 och vi var nyfikna på vilka intrycken är från den första tiden. Ögonsjukdomar, som t.ex. åldersförändringar i gula fläcken är en folksjukdom och vi belyser de krav som ställs på ögonsjukvården framöver, inte minst med tanke på en ökande och allt äldre befolkning. Det är viktigt att fokusera mera på en behovsanpassad ögonsjukvård och få till ett närmare samarbete med patienterna. Artificiell intelligens och distansmonitorering, samt olika digitaliserade vårdlösningar är vägen framåt. Det är också viktigt att säkerställa en kontinuerlig utbildning av läkare inom primärvård. S:t Erik lgger långt framme när det gäller forskning och man strävar efter att vara ett Eye center of excellence. Frågor eller synpunkter? eyepod@bayer.com    MA-M_AFL-DK-0198-1 

Welcome to Eyepod Bayer! Today we are presenting another Viewpoint from the Vision academy. The title of the Viewpoint is: Coordinated Care in Diabetic Eye Disease Management We would be happy to hear your feedback. eyepod@bayer.com MA-M_AFL-DK-0177-1    

Välkomna till EyePod! Det här är en förkortad återsändning av avsnitt 8 från 2019, där vi  intervjuade Tord Jonsson. Tord är pensionerad läkare och har själv AMD. I den längre versionen diskuterade vi också det svenska makularegistret och hur registret kan användas av patienter. Den ursprungliga intervjun: https://open.spotify.com/episode/12X6w5XSVB6bJrwxZVfzQS   eyepod@bayer.com MA-M_AFL-DK-0178-1    

Welcome to Eyepod Bayer! Today we are presenting another Viewpoint from the Vision academy. The title of the Viewpoint is: Monitoring of the Fellow Eye in Neovascular Age-Related Macular Degeneration. All viewpoints can be found at www.visionacademy.org/resources   EyePod@Bayer.com MA-M_AFL-DK-0176-1  

Welcome to EyePod Bayer! In the upcoming episodes we will focus on Viewpoints from the Vision Academy. The Vision Academy is a partnership between Bayer and ophthalmic specialists, established with the aim of addressing key clinical challenges in the field of retinal diseases. Today we are presenting the viewpoint: Bilateral Anti-VEGF treatment and I have my colleague and medical advisor Haleh Davanian with me. EyePod@Bayer.com MA-M_AFL-DK-0175-1  

Welcome to EyePod Bayer and the second episode with Dr Johan Germundsson, about Refractive lens exchange and other refractive intraocular options. EyePod@Bayer.com   MA-M_AFL-DK-0173-1

Welcome to EyePod Bayer! The following two episodes, where we have Memira Eyecenter as our guest, will be focusing on refractive surgery, including laser techniques and refractive lens extraction, and we have the honor to welcome Dr Johan Germundsson as our expert and distinguished guest for this session. Enjoy! EyePod@Bayer.com MA-M_AFL-DK-0171-1      

Welcome to EyePod Bayer and this exciting follow-up episode about uveal tumors, with Dr Charlotta All-Eriksson. Enjoy and please let us know your thoughts of this episode EyePod@Bayer.com MA-M_AFL-DK-0170-1    

Welcome to EyePod Bayer and this exciting episode about conjunctival tumors, with Dr Charlotta All-Eriksson. This is the first part of two. In the second part we will discuss uveal tumors. Enjoy and please let us know your thoughts of this episode EyePod@Bayer.com   MA-M_AFL-DK-0150-1

Välkommen till EyePod Bayer och en mycket spännande intervju med Markus Karlsson som berättar om hur han förverkligade sin dröm om att starta en helt egen ögonklinik.    eyepod@bayer.com MA-M_AFL-DK-0102-1    

Welcome to EyePod Bayer! Enjoy this follow-up episode with Dr Mario Economou. Let us hear your thoughts! eyepod@bayer.com MA-M_AFL-DK-0100-1    

Welcome back to a new episode of EyePod Bayer, this time about glaucoma.  Here in this first part, we talk about medical glaucoma together with Dr Mario Economou. The second part will be about surgical glaucoma.   Enjoy and let us hear your thoughts! eyepod@bayer.com   MA-M_AFL-DK-0095-1

Welcome back to EyePod Bayer! This is the second episode with Dr Eva Olofsson from Umeå University Hospital. The following episode will be focusing on macular surgery - specifically macular hole and pucker. Welcome to listen! eyepod@bayer.com MA-M_AFL-DK-0094-1    

Welcome to EyePod Bayer!  In the following episode we will be focusing on endophthalmitis, and we have the honor to welcome Dr Eva Olofsson from Umeå University Hospital, a vitreoretinal surgeon, and the chairman of the Swedish Society of Ophthalmology, as our expert and distinguished guest for this session. Did you like the interview? Let us know your thoughts! eyepod@bayer.com MA-M_AFL-DK-0093-1  

Welcome back to Eyepod! The following episode will be focusing on handling of non-infectious-uveitis patients, and we have the honor to welcome Dr Avinash Gurbaxani from Moorfields Eye Hospital Dubai as our expert and distinguished guest for this session. Welcome!  eyepod@bayer.com MA-M_AFL-DK-0086-1

Welcome to a new episode of EyePod Bayer! In this special episode, you will hear more about congenital aniridia, a rare but devastating pan-ocular disease resulting from mutations in the PAX6 gene. To bring together the various existing efforts to understand, manage, and treat aniridia, ANIRIDIA-NET was established. Stay tuned to hear more about it! Appearing in this podcast: Prof. Neil Lagali Prof. Dominique Bremond-Gignac Juliana Martinez Ivana Kildsgaard Questions? eyepod@bayer.com MA-M_AFL-DK-0071-2    

Welcome to EyePod Bayer!   In this episode, we talk about stem cells with prof Tor Paaske Utheim!    eyepod@bayer.com MA-M_AFL-DK-0079-1  

Welcome to EyePod Bayer! In this episode, we talk about dry eye disease.   eyepod@bayer.com MA-M_AFL-DK-0070-1        

Welcome to EyePod Bayer!   In this episode we talk about Sars-Cov-2 effects on the vessels.   Enjoy! eyepod@bayer.com MA-M_AFL-DK-0067-1      

Welcome to EyePod Bayer!   In this episode, we have our two guests back, professor Neil Lagali and assoc. professor Lasse Jensen at Linköping University. Today, we talk about experimental models in ophthalmological research. Lasse and Neil have been on EyePod before in episode 5 talking about Mechanisms of angiogenesis in the eye and Future treatments of ocular angiogenesis.   Welcome!   Eyepod@bayer.com   MA-M_AFL-DK-0056-1    

Welcome to EyePod Bayer and a summary of the Nordic Retina Meeting, arranged by Bayer Scandinavia on the 4th - 5th of Feb 2021. The first day focused on the treatment regimens, follow-up and how to exit treatment of nAMD, followed the second day about clinical experiences from the Nordic countries and treatment regimens of RVO, and finally a session on Quality of life and resource allocation for patients with visual impairment. Here, we give you a short summary including some segments from the meeting. -Treatment regimens in nAMD with prof Jean-Francois Korobelnik -Imaging in nAMD and RVO with prof Giovanni Staurenghi -Exit treatment in nAMD patients with prof Justus Garweg and Dr Stamatios Aslanis -Introduction to RVO with Dr Elin Gunnlaugsdottir -Health Economy and Quality of Life with prof Hannu Uusitalu   Let us know if you liked this summary by sending us an e-mail. If you are from Scandinavia, let us know if you want the recordings. eyepod@bayer.com   MA-M_AFL-DK-0061-1

Welcome back to EyePod Bayer and another episode of this imaging series. Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT-A can be used as a tool in the management of diabetic retinopathy. This is the third part where we will continue to talk about OCT-A in Diabetic Retinopathy! Did you like this episode? Let us know your thoughts! eyepod@bayer.com MA-M_AFL-DK-0045-1    

Welcome back to EyePod Bayer and another episode of this imaging series. Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT-A can be used as a tool in the management of diabetic retinopathy. Stay tuned for the third part where we will continue to talk about OCT-A in Diabetic Retinopathy! Did you like this episode? Let us know your thoughts! eyepod@bayer.com MA-M_AFL-DK-0044-1

Welcome to EyePod Bayer! In this episode, our moderators professor Michael Larsen and Dr Elin Gunnlaugsdottir gives us all their reasons to why you should register to attend the virtual Nordic Retina Meeting 2021, which will be on 4-5th of February 2021, with both Nordic and international speakers.  This is an reminder, to those of you in the Nordic countries who have already received an invitation, to register. Link to agenda and registration (agenda at the bottom): lyyti.fi/reg/Bayer_4546/se or e-mail to eyepod@bayer.com MA-M_AFL-DK-0025-1    

Welcome back to EyePod Bayer and another episode of this imaging series. Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT or OCT-angiography can be used as a tool in the management of diabetic retinopathy. In this first part, we will focus on OCT. Stay tuned for the second part where we talk about OCT-A in Diabetic Retinopathy! Did you like this episode? Let us know your thoughts! eyepod@bayer.com MA-M_AFL-DK-0036-1

Welcome to a new episode of this imaging series on EyePod Bayer. In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD. This is the third part of the interview with Neil and Stamatis, where we talk about OCT-A in clinical practice with focus on wet AMD. In the next interviews, we will talk about OCT and OCT-A in Diabetic Retinopathy, stay tuned!  Enjoy! eyepod@bayer.com   MA-M_AFL-DK-0032-1    

Welcome to a new episode of this imaging series on EyePod Bayer. In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD. This is the second part of the interview with Neil and Stamatis, where we talk about OCT in clinical practice with focus on wet AMD. In the next part, we will talk about OCT-A, stay tuned!  Enjoy! eyepod@bayer.com MA-M_AFL-DK-0024-1

Welcome to a new episode of this imaging series on EyePod Bayer. In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD. This is the first part of the interview with Neil and Stamatis, where we talk about OCT in general. In the next part, we will talk about OCT in nAMD.  Enjoy! eyepod@bayer.com MA-M_AFL-DK-0024-1    

Welcome to EyePod Bayer! In this episode, our moderators professor Michael Larsen and Dr Elin Gunnlaugsdottir gives us all their reasons to why you should register to attend the virtual Nordic Retina Meeting 2021, which will be on 4-5th of February 2021, with both Nordic and international speakers.  This is an reminder, to those of you in the Nordic countries who have already received an invitation, to register. Link to agenda and registration (agenda at the bottom): lyyti.fi/reg/Bayer_4546/se or e-mail to eyepod@bayer.com MA-M_AFL-DK-0025    

Welcome back to EyePod and the third episode of the imaging series, where we will continue to interview Neil Lagali and Berit Byström from the last episode.  In the future episodes in the imaging series, we will talk about OCT and OCT-A in wet AMD, followed by Diabetic Retinopathy. Stay tuned!  eyepod@bayer.com   MA-M_AFL-DK-0021-1    

Welcome back to EyePod and the second episode of the imaging series, where we will continue to interview Neil Lagali from the last episode. Today we would also like to express a special welcome to a new guest, Berit Byström, assistant professor and consultant at the Eye Department at Umeå University.  This episode will focus on how we can apply confocal imaging technique in the clinic - When to use it and how to interpret the outcome of the examination. Enjoy! eyepod@bayer.com   MA-M_AFL-DK-0019-1    

Welcome back to EyePod Bayer! This exciting episode will be the first in a series of interesting interviews and discussions about imaging of the eye. We will start in the anterior part, with confocal microscopy of the cornea, and continue with imaging of the back of the eye and retina with OCT and OCT-A.With us today we have Neil Lagail, from the Institution for Biomedical and Clinical Sciences at Linköping University. Neil is professor and internationally recognized expert in confocal microscopy. This is his second visit to the EyePod and last time he shared his knowledge in angiogenesis in the eye. Today we are looking forward to discussing the background and technical aspects of confocal microscopy of the cornea. In a second episode, we will invite Dr Berit Byström, assistant professor and consultant at the Eye Department at Umeå University, to discuss the clinical application with this interesting imaging technique.      eyepod@bayer.com   MA-M_AFL-DK-0018    

Hello and welcome to EyePod Bayer! Register: eyepod@bayer.com or https://www.lyyti.fi/reg/VAWebinar This is a revisit of our previously published episode “What is Vision Academy”. On November 3rd 2020, Bayer Scandinavia is hosting an online meeting together with Vision Academy, with the topic Addressing Clinical Challenges In Ophthalmology.  The webinar will include two live debates on key clinical challenges in ophthalmology and is chaired by Professor Anat Loewenstein of Tel Aviv University. Topics will be debated by Vision Academy members Dr. David Wong of the University of Toronto and Dr. Monica Lövestam-Adrian of Lund University. You will be able to participate in the Q&A session This is a meeting for health care professionals in our Nordic and Baltic countries, who have already received an invitation. If you who have been invited would like to register to the meeting, please send an e-mail to eyepod@bayer.com or follow the link below https://www.lyyti.fi/reg/VAWebinar   Thank you!   MA-M_AFL-DK-0016-1

Welcome to a new episode of EyePod Bayer! In this episode, we are talking about EURETINA 2020 together with Dr Pierfrancesco Mirabelli from Linköping University Hospital. Comments? eyepod@bayer.com   MA-M_AFL-DK-0014-1

Welcome to a new episode of EyePod Bayer! In todays episode, we are talking with Tomer Feffer, CEO of Bayer Scandinavia and Anders Blanck, Administrative Director, LIF (The research-based pharmaceutical industry / Läkemedelsföretagens Intresseförening).   Let us know your thoughts! eyepod@bayer.com     MA-EYL-DK-0142-1

Välkomna till ett nytt avsnitt av EyePod Bayer där vi ska prata om psykisk hälsa med fokus på ögonsjukvården.Med oss idag har vi Åsa Kadowaki, legitimerad psykiatriker och legitimerad KBT-terapeut. Dagens intervju görs av Beatrice Peebo medicinsk rådgivare på Bayer.   eyepod@bayer.com   MA-EYL-DK-0139    

Hej och välkomna till EyePod I detta avsnitt har vi bjudit in fysioterapeut och ergonom Märta Remneblad från Linköping som ger oss tips om hur vi ska arbeta för att undvika förslitningsskador.    eyepod@bayer.com

Welcome to EyePod Bayer! Today we have the honor to welcome Ann Hellström, Professor in Pediatric Ophthalmology at the Institute of Neuroscience and Physiology at The Queen Silvia Children’s Hospital, Gothenburg, Sweden. She will share with us her experiences and expertise as a clinician and researcher in Retinopathy of Prematurity also known as ROP.   Did you like this interview? Looking forward to hear your thoughts! eyepod@bayer.com   MA-EYL-DK-0135

Welcome to EyePod Bayer! Today we have the honor to welcome Ann Hellström, Professor in Pediatric Ophthalmology at the Institute of Neuroscience and Physiology at The Queen Silvia Children’s Hospital, Gothenburg, Sweden. She will share with us her experiences and expertise as a clinician and researcher in Retinopathy of Prematurity also known as ROP.   Did you like this interview? Looking forward to hear your thoughts! eyepod@bayer.com   MA-EYL-DK-0134

Welcome to EyePod Bayer! Today we have the honor to welcome Ann Hellström, Professor in Pediatric Ophthalmology at the Institute of Neuroscience and Physiology at The Queen Silvia Children’s Hospital, Gothenburg, Sweden. She will share with us her experiences and expertise as a clinician and researcher in Retinopathy of Prematurity also known as ROP.   Did you like this interview? Looking forward to hear your thoughts! eyepod@bayer.com MA-EYL-DK-0133

Välkomna till ett nytt avsnitt av EyePod Bayer!   eyepod@bayer.com    

Welcome to another episode of EyePod Bayer related to the ongoing Covid-19 pandemic. In this episode, we are honored to have Professor Paolo Lanzetta, Founder and Scientific Director at European Institute for ocular microsurgery in Udine. Dr Lanzetta is one of the members in the Vision Academy Steering Committee and will share his insights of the guidelines and give us an update from the situation in Italy. In our discussions, we refer to the recently published paper in Graefe's Archive for Clinical and Experimental Ophthalmology: Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. This paper was authored by the network Vision Academy, sponsored by Bayer, which is an international group of retinal experts who collaborate to share existing skills and knowledge in retinal diseases. Let us know your thoughts by sending an e-mail!  eyepod@bayer.com MA-EYL-DK-0129-1

Welcome to another Covid-19 special episode of EyePod Bayer! Today we are going to discuss how the current situation can affect treatment of patients with intravitreal injections and we will refer to a recently published paper in Graefe's Archive for Clinical and Experimental Ophthalmology: Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. This paper was authored by the network Vision Academy, sponsored by Bayer, which is an international group of retinal experts who collaborate to share existing skills and knowledge in retinal diseases. The recommendations published in the paper were developed during a virtual meeting in March 2020 by the 14-member-Vision Academy Steering Committee. Already available guidance documents for patients receiving intravitreal injections of anti-VEGF agents during the COVID-19 pandemic were reviewed, debated and summarized in the paper. In only 18 days the manuscript was finalized, submitted and accepted for publication, which probably makes it one of the fastest publications in history! In this episode, we are honored to have Monica Lövestam-Adrian, Head of the Medical Retina Department at Lund University Hospital and Associate Professor in Ophthalmology at Lund University in Sweden. Monica is one of the members in the Vision Academy Steering Committee and will share her insights of the guidelines with us today.  For contact:eyepod@bayer.com   MA-EYL-DK-0127-1

Välkomna till ett nytt avsnitt av EyePod Bayer! Det här avsnittet spelar vi in med anledning av Covid-19 pandemin. Vi blir alla påverkade på ett eller annat sätt vilket kan leda till oro i samhället, framför allt när vi inte vet hur länge det kommer att pågå. Därför känner vi att det skulle vara värdefullt att få råd om hur man kan förhålla sig till de nya omständigheterna. Med oss idag har vi därför Åsa Kadowaki, legitimerad psykiatriker och legitimerad psykoterapeut.Dagens intervju görs av Beatrice Peebo medicinsk rådgivare på Bayer. Låt oss veta vad du tyckte! eyepod@bayer.com MA-EYL-DK-0124-1

Välkomna till EyePod Bayer och detta special-avsnitt som ger oss en rapport direkt från ögonsjukvården. Vi har fått chansen att prata med Sten Kjellström som är ordförande i Sveriges ögonläkarförening, verksamhetschef vid Skånes Universitetssjukhus och själv ögonläkare, för att ställa ett par frågor och få en rapport direkt från kliniken gällande hur Covid-19 påverkar vården för våra ögonpatienter.  Frågor och synpunkter är välkomna! eyepod@bayer.com   MA-EYL-DK-0126-1    

Välkomna till EyePod Bayer och den sista delen med Marita Grönlund som ska handla om CVI!   eyepod@bayer.com     MA-EYL-DK-0119  

Välkomna till EyePod Bayer! Som vår gäst idag har vi äran att välkomna docent Marita Andersson Grönlund vid Sahlgrenska universitetssjuhuset. Vårt samtal idag handlar om barnuveiter med särskilt fokus på JIA-relaterad irit (JIA - Juvenile idiopathic arthritis), och i ett andra avsnitt om Cortical Visual Impairment (CVI). Marita Grönlund är en av våra ledande experter på området i Sverige och vi är mycket glada och tacksamma för denna intervju där hon delar sina kunskaper och erfarenheter inom barnoftalmologi. Välkomna att lyssna och berätta gärna vad ni tycker med ett kort mail, tack! eyepod@bayer.com   MA-EYL-DK-0115    

Välkomna till EyePod Bayer! Som vår gäst idag har vi äran att välkomna docent Marita Andersson Grönlund vid Sahlgrenska universitetssjuhuset. Vårt samtal idag handlar om barnuveiter med särskilt fokus på JIA-relaterad irit (JIA - Juvenile idiopathic arthritis), och i ett andra avsnitt om Cortical Visual Impairment (CVI). Marita Grönlund är en av våra ledande experter på området i Sverige och vi är mycket glada och tacksamma för denna intervju där hon delar sina kunskaper och erfarenheter inom barnoftalmologi. Välkomna att lyssna och berätta gärna vad ni tycker med ett kort mail, tack! eyepod@bayer.com MA-EYL-DK-0113-1

Welcome back to EyePod Bayer! Today we will discuss an important topic for many of our patients and those of you active within the Ophthalmological Society – namely the Swedish Cataract Register which started in 1992 and is highly recognized and well known within as well as outside the Swedish borders.   The primary aim of the register was to assess waiting time for cataract surgery and BCVA at the time for surgery and has evolved to include outcome of visual function, quality data and incidence of endophthalmitis.  So far the register has contributed to numerous publications with important and helpful outcomes and guidance, valuable both for patients and for cataract surgeons all over the world. It is with honor and joy we welcome today Professor Anders Behndig, currently responsible for the cataract register and Professor Mats Lundström, founder of the register. Welcome! eyepod@bayer.com   MA-EYL-DK-0110-1